期刊文献+

脂蛋白磷脂酶A2基因I198T和R92H多态性与中国汉族人群冠心病的相关性 被引量:3

Association of I198T,R92H polymorphisms in lipoprotein-associated phospholipase A2 gene with coronary heart disease in the Chinese Han population
下载PDF
导出
摘要 目的:探讨脂蛋白磷脂酶A2基因I198T和R92H多态性位点与中国汉族人群冠心病遗传易感性的关系。方法:纳入173例冠心病患者和101例对照者,应用DNA测序仪测脂蛋白磷脂酶A2基因I198T和R92H的基因型。结果:①冠心病组I198T的基因型和等位基因频率与对照组无明显差异,而R92H的基因型和等位基因频率明显高于对照组(P〈0.05);②RH+HH基因型者总胆固醇和低密度脂蛋白胆固醇的水平高于RR基因型者(P〈0.01);③IH单倍型与IR单倍型在冠心病组和对照组中的分布均有显著性差异(P〈0.01);④Logistic回归分析表明R92H的等位基因92H是冠心病的独立危险因素。结论:脂蛋白磷脂酶A2基因I198T多态性与汉族人群冠心病无明显相关性,R92H多态性与汉族人群冠心病独立相关。 Objective:To investigate the association of I198T and R92H point mutations in lipoprotein-associated phospholipaseA2(Lp-PLA2)with coronary heart disease(CHD) in the Chinese Han population.Methods:Totally 173 CHD patients and 101 normal controls were genotyped by DNA sequencing instrument.Results:There was no significant difference between the CHD group and the control group in the frequencies of I198T genotypes and allele,but the frequencies of the R92H genotypes and allele were significantly higher in CHD patients than those in normal controls(P 0.05).The levels of total cholesterol(TC)and low density lipoprotein cholesterol(LDL-C)were significantly higher in the RH+HH genotype group than in the RR genotype group(P 0.01).The distributions of haplotype IH and IR had a significant difference(P 0.01)between CHD patients and normal controls.Binary logistic regression analysis demonstrated that polymorphism of R92H was an independent risk factor for CHD.Conclusion:The I198T polymorphism of Lp-PLA2 gene has no significant correlation with coronary heart disease,while the polymorphism of R92H could be associated with risk of CHD in Chinese Han population.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2013年第1期73-77,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省自然科学基金(BK2009450) 江苏省社会发展基金(BE2011804)
关键词 脂蛋白磷脂酶A2 基因 多态性 冠心病 lipoprotein-associated phospholipase A2 gene polymorphism coronary heart disease
  • 相关文献

同被引文献32

  • 1刘甲兴,郑兴,秦永文,丁继军,赵仙先,曹江.脂蛋白相关性磷脂酶A_2活性能反映冠状动脉粥样硬化病变程度[J].第二军医大学学报,2006,27(4):391-395. 被引量:31
  • 2Kleber ME, Siekmeier R, Delgado G, et al. C-reactive protein and lipoprotein-associated phospbolipase A2 in smokers and non- smokers of the Ludwigshafen Risk and Cardiovascular Health study [J]. Adv Exp Med Biol, 2015,832:15-23.
  • 3Wang Y, Zbang J, Qian Y, et al. Association of Lp-PLA2 Mass and Aysmptomatic Intracranial and Extracranial Arterial Stenosis in Hypertension Patients[J]. PLoS One, 2015,10(6): e0 130 473.
  • 4Garg S, Madhu SV, Suneja S. Lipoprotein associated phospholi- pase A2 activity & its correlation with oxidized LDL & glycaemic status in early stages of type- 2 diabetes mellitus[J]. Indian J Med Res, 2015,141 ( 1 ):107-114.
  • 5da Silva IT, de Almeida-Pititto , Ferreira SR. Reassessing lipid metabolism and its potentialities in the prediction of cardiovascular risk[J]. Arch Endocrinol Metab, 2015, 59(2):171-180.
  • 6Tsimikas S, Tsironis LD, Tselepis AD. New insights into the role of lipoprotein ( a ) - associated lipoprotein- associated phospholipase A2 in atherosclerosis and cardiovascular disease[J]. Arterioseler Thromb Vase Biol, 2007,27( 10):2094-2099.
  • 7Mahalka AK, Kinnunen PK. Class specific peptide inhibitors for secretory phospholipases A2[J]. Biochem Biophys Res Commun, 2013,436(2):349-353.
  • 8Acevedo M, Varleta P, Kramer V, et al. Comparison of Lipopro- tein-Associated Phospholipase A2 and High Sensitive C-Reactive Protein as Determinants of Metabolic Syndrome in Subjects without Coronary Heart Disease: In Search of the Best Predictor[J]. Int J En-docrinol,2015, 2015:934 681.
  • 9Corson M, Jones PH, Davidson MH. , et al. Review of the evidence for the clinical utility of lipoprotein- associated phospholipase A2 as a cardiovascular risk marker[J]. Am J Cardiol, 2008, 101 ( 12A): 41F-50F.
  • 10Toth PP, McCullough PA, Wegner MS, et al. Lipoprotein-associ- ated phospholipase A2: role in atherosclerosis and utility as a cardiovascular biomarker[J]. Expert Rev Cardiovasc Ther, 2010, 8 ( 3 ) :425-438.

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部